Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	proteasome activator complex	PSME1 PSME2	1.36e-05	3	45	2	GO:0008537
GeneOntologyCellularComponent	proteasome complex	USP25 PSME1 PSME2	4.06e-04	67	45	3	GO:0000502
Domain	-	PSME1 PSME2	1.70e-05	3	45	2	1.20.5.120
Domain	PA28_alpha	PSME1 PSME2	1.70e-05	3	45	2	PF02251
Domain	PA28_beta	PSME1 PSME2	1.70e-05	3	45	2	PF02252
Domain	Proteasome_activ_pa28_C	PSME1 PSME2	1.70e-05	3	45	2	IPR003186
Domain	Proteasome_activ_pa28_N	PSME1 PSME2	1.70e-05	3	45	2	IPR003185
Domain	ELL	ELL3 ELL	1.70e-05	3	45	2	PF10390
Domain	-	PSME1 PSME2	1.70e-05	3	45	2	1.20.120.180
Domain	ELL_N	ELL3 ELL	1.70e-05	3	45	2	IPR019464
Domain	Proteasome_activ_pa28	PSME1 PSME2	3.40e-05	4	45	2	IPR009077
Domain	Occludin_ELL	ELL3 ELL	8.46e-05	6	45	2	IPR010844
Domain	ELL/occludin	ELL3 ELL	8.46e-05	6	45	2	IPR031176
Domain	Occludin_ELL	ELL3 ELL	8.46e-05	6	45	2	PF07303
Domain	TPR_2	GPSM1 KLC3	6.46e-03	50	45	2	PF07719
Domain	TPR_2	GPSM1 KLC3	6.46e-03	50	45	2	IPR013105
Pathway	REACTOME_S_PHASE	UBE2S MCM4 AKT2 PSME1 PSME2	3.71e-05	146	37	5	MM15378
Pathway	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	UBE2S MCM4 PSME1 PSME2	5.78e-05	81	37	4	MM15360
Pathway	REACTOME_S_PHASE	UBE2S MCM4 AKT2 PSME1 PSME2	6.28e-05	163	37	5	M3158
Pathway	REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE	UBE2S MCM4 PSME1 PSME2	8.73e-05	90	37	4	MM15371
Pathway	REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE	UBE2S MCM4 PSME1 PSME2	9.51e-05	92	37	4	M27666
Pathway	REACTOME_DNA_REPLICATION_PRE_INITIATION	UBE2S MCM4 PSME1 PSME2	1.17e-04	97	37	4	MM15369
Pathway	REACTOME_G1_S_TRANSITION	MCM4 AKT2 PSME1 PSME2	1.53e-04	104	37	4	MM15376
Pathway	REACTOME_SYNTHESIS_OF_DNA	UBE2S MCM4 PSME1 PSME2	2.74e-04	121	37	4	M5224
Pathway	REACTOME_KEAP1_NFE2L2_PATHWAY	AKT2 AMER1 PSME1 PSME2	3.10e-04	125	37	4	M45021
Pathway	REACTOME_DNA_REPLICATION	UBE2S MCM4 PSME1 PSME2	3.10e-04	125	37	4	MM15380
Pathway	REACTOME_CELL_CYCLE	UBE2S MCM4 AKT2 NCAPH2 PSME1 PSME2 CENPF SYNE2	3.59e-04	694	37	8	M543
Pathway	REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	MCM4 AKT2 PSME1 PSME2	3.60e-04	130	37	4	MM15146
Pathway	REACTOME_CELL_CYCLE_MITOTIC	UBE2S MCM4 AKT2 NCAPH2 PSME1 PSME2 CENPF	5.54e-04	561	37	7	M5336
Pathway	REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	MCM4 AKT2 PSME1 PSME2	6.04e-04	149	37	4	M848
Pathway	REACTOME_CELL_CYCLE_CHECKPOINTS	UBE2S MCM4 PSME1 PSME2 CENPF	6.67e-04	271	37	5	MM15388
Pathway	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	AKT2 AMER1 PSME1 PSME2	7.52e-04	158	37	4	MM14791
Pathway	REACTOME_DNA_REPLICATION_PRE_INITIATION	UBE2S MCM4 PSME1 PSME2	7.70e-04	159	37	4	M27665
Pathway	REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY	AKT2 PSME1 PSME2	7.74e-04	69	37	3	MM15540
Pathway	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	MCM4 PSME1 PSME2	7.74e-04	69	37	3	MM15366
Pathway	REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY	AKT2 PSME1 PSME2	7.74e-04	69	37	3	M27815
Pathway	REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	AKT2 PSME1 PSME2	8.07e-04	70	37	3	MM15389
Pathway	REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	UBE2S PSME1 PSME2	8.41e-04	71	37	3	MM15370
Pathway	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	MCM4 PSME1 PSME2	8.41e-04	71	37	3	M4138
Pathway	REACTOME_CELL_CYCLE	UBE2S MCM4 AKT2 NCAPH2 PSME1 PSME2 CENPF	8.50e-04	603	37	7	MM14635
Pathway	REACTOME_CELL_CYCLE_CHECKPOINTS	UBE2S MCM4 PSME1 PSME2 CENPF	9.19e-04	291	37	5	M16647
Pathway	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	UBE2S PSME1 PSME2	9.49e-04	74	37	3	MM14678
Pathway	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	UBE2S PSME1 PSME2	9.49e-04	74	37	3	M1030
Pathway	REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	UBE2S PSME1 PSME2	1.07e-03	77	37	3	MM14692
Pathway	REACTOME_KEAP1_NFE2L2_PATHWAY	AKT2 PSME1 PSME2	1.07e-03	77	37	3	MM15698
Pathway	REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX	AMER1 PSME1 PSME2	1.15e-03	79	37	3	MM14754
Pathway	REACTOME_DNA_REPLICATION	UBE2S MCM4 PSME1 PSME2	1.41e-03	187	37	4	M1017
Pathway	REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	AKT2 PSME1 PSME2	1.42e-03	85	37	3	M27674
Pathway	REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX	AMER1 PSME1 PSME2	1.42e-03	85	37	3	M27079
Pathway	REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	UBE2S PSME1 PSME2	1.52e-03	87	37	3	MM14677
Pathway	REACTOME_SEPARATION_OF_SISTER_CHROMATIDS	UBE2S PSME1 PSME2 CENPF	1.52e-03	191	37	4	M29614
Pathway	REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	UBE2S PSME1 PSME2	1.57e-03	88	37	3	M29582
Pathway	REACTOME_SEPARATION_OF_SISTER_CHROMATIDS	UBE2S PSME1 PSME2 CENPF	1.58e-03	193	37	4	MM14890
Pathway	REACTOME_PTEN_REGULATION	AKT2 PSME1 PSME2	2.13e-03	98	37	3	MM15348
Pathway	REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS	AKT2 AMER1 PSME1 PSME2	2.15e-03	210	37	4	M41836
Pathway	WP_GASTRIC_CANCER_NETWORK_1	MCM4 CENPF	2.43e-03	28	37	2	M39347
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CEP350 AFDN CLINT1 MPHOSPH9 AMER1 TMCC3 KLC3 SYNE2 SEC16A	1.34e-06	861	45	9	36931259
Pubmed	High yield bacterial expression and purification of active recombinant PA28alphabeta complex.	PSME1 PSME2	1.64e-06	2	45	2	19017543
Pubmed	In vivo characterization of the proteasome regulator PA28.	PSME1 PSME2	1.64e-06	2	45	2	8663520
Pubmed	Relative functions of the alpha and beta subunits of the proteasome activator, PA28.	PSME1 PSME2	1.64e-06	2	45	2	9346951
Pubmed	PA28αβ overexpression enhances learning and memory of female mice without inducing 20S proteasome activity.	PSME1 PSME2	1.64e-06	2	45	2	30400847
Pubmed	The role of the proteasome activator PA28 in MHC class I antigen processing.	PSME1 PSME2	1.64e-06	2	45	2	12200048
Pubmed	Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing.	PSME1 PSME2	1.64e-06	2	45	2	12119343
Pubmed	Allele-selective effect of PA28 in MHC class I antigen processing.	PSME1 PSME2	1.64e-06	2	45	2	18641301
Pubmed	Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome.	PSME1 PSME2	1.64e-06	2	45	2	7789512
Pubmed	Expression and subcellular localization of mouse 20S proteasome activator complex PA28.	PSME1 PSME2	1.64e-06	2	45	2	9287111
Pubmed	The Mammalian Proteasome Activator PA28 Forms an Asymmetric α4β3 Complex.	PSME1 PSME2	1.64e-06	2	45	2	28867616
Pubmed	Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.	PSME1 PSME2	1.64e-06	2	45	2	11689430
Pubmed	Impaired immunoproteasome assembly and immune responses in PA28-/- mice.	PSME1 PSME2	1.64e-06	2	45	2	10591649
Pubmed	Organization of the genes encoding the human proteasome activators PA28alpha and beta.	PSME1 PSME2	4.91e-06	3	45	2	10199920
Pubmed	Sequence and expression of mouse proteasome activator PA28 and the related autoantigen Ki.	PSME1 PSME2	4.91e-06	3	45	2	9162094
Pubmed	Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress.	PSME1 PSME2	4.91e-06	3	45	2	22308036
Pubmed	Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei.	PSME1 PSME2	4.91e-06	3	45	2	10567354
Pubmed	N-α-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β.	PSME1 PSME2	4.91e-06	3	45	2	23624078
Pubmed	Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators.	PSME1 PSME2	4.91e-06	3	45	2	9325261
Pubmed	Antiangiogenic tumor therapy by DNA vaccine inducing aquaporin-1-specific CTL based on ubiquitin-proteasome system in mice.	PSME1 PSME2	4.91e-06	3	45	2	22802414
Pubmed	Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.	PSME1 PSME2	4.91e-06	3	45	2	9620878
Pubmed	Characterization of the mouse PA28 activator complex gene family: complete organizations of the three member genes and a physical map of the approximately 150-kb region containing the alpha- and beta-subunit genes.	PSME1 PSME2	4.91e-06	3	45	2	9590240
Pubmed	PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection.	PSME1 PSME2	4.91e-06	3	45	2	28278207
Pubmed	The ubiquitin-proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cells.	PSME1 PSME2	4.91e-06	3	45	2	16569681
Pubmed	Conformational maps of human 20S proteasomes reveal PA28- and immuno-dependent inter-ring crosstalks.	PSME1 PSME2	4.91e-06	3	45	2	33262340
Pubmed	Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.	MCM4 CENPF	4.91e-06	3	45	2	20398247
Pubmed	Circadian modulation of proteasome activity and accumulation of oxidized protein in human embryonic kidney HEK 293 cells and primary dermal fibroblasts.	PSME1 PSME2	4.91e-06	3	45	2	26944190
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CEP350 POR AFDN CLINT1 MPHOSPH9 AMER1 SMC6 SEC16A	6.21e-06	777	45	8	35844135
Pubmed	Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.	PSME1 PSME2	9.81e-06	4	45	2	22564544
Pubmed	Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.	PSME1 PSME2	1.63e-05	5	45	2	15356141
Pubmed	The mouse Supt16h/Fact140 gene, encoding part of the FACT chromatin transcription complex, maps close to Tcra and is highly expressed in thymus.	PSME1 PSME2	1.63e-05	5	45	2	11471063
Pubmed	Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii.	PSME1 PSME2	1.63e-05	5	45	2	31608052
Pubmed	The immunoproteasome subunit LMP7 is required in the murine thymus for filling up a hole in the T cell repertoire.	PSME1 PSME2	1.63e-05	5	45	2	29067678
Pubmed	PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.	PSME1 PSME2	1.63e-05	5	45	2	21360704
Pubmed	Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver.	PSME1 PSME2	1.63e-05	5	45	2	23209186
Pubmed	[Application of reverse transcription-multiplex nested PCR to detect MLL rearrangement in AML-M4/M5].	AFDN ELL	1.63e-05	5	45	2	16086288
Pubmed	Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.	PSME1 PSME2	1.63e-05	5	45	2	12519221
Pubmed	Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.	PSME1 PSME2	2.45e-05	6	45	2	22772448
Pubmed	Antigen presentation by MHC class I and its regulation by interferon gamma.	PSME1 PSME2	2.45e-05	6	45	2	10047537
Pubmed	Effector-mediated subversion of proteasome activator (PA)28αβ enhances host defense against Legionella pneumophila under inflammatory and oxidative stress conditions.	PSME1 PSME2	2.45e-05	6	45	2	37347796
Pubmed	Nucleotide sequence analysis of the approximately 35-kb segment containing interferon-gamma-inducible mouse proteasome activator genes.	PSME1 PSME2	2.45e-05	6	45	2	11345588
Pubmed	Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells.	PSME1 PSME2	2.45e-05	6	45	2	15944286
Pubmed	Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.	PSME1 PSME2	2.45e-05	6	45	2	19403671
Pubmed	Genetic relationships of the genes encoding the human proteasome beta subunits and the proteasome PA28 complex.	PSME1 PSME2	2.45e-05	6	45	2	9344661
Pubmed	Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis.	PSME1 PSME2	3.42e-05	7	45	2	10799514
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	AFDN PSME1 CENPF SMC6 SEC16A	4.53e-05	304	45	5	32235678
Pubmed	Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation.	PSME1 PSME2	7.32e-05	10	45	2	11745344
Pubmed	NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses.	PSME1 SEC16A	8.94e-05	11	45	2	31114588
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CEP350 AFDN CLINT1 MPHOSPH9 AMER1 PSME1 ELL	1.05e-04	853	45	7	28718761
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	ELL3 ELL	1.07e-04	12	45	2	22195968
Pubmed	Defining the membrane proteome of NK cells.	CEP350 POR MCM4 CLINT1 NCAPH2 MPHOSPH9 PSME2 PSD4	1.13e-04	1168	45	8	19946888
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CENPF HSPA4L SYNE2 SEC16A	1.24e-04	197	45	4	20811636
Pubmed	PA28 subunits of the mouse proteasome: primary structures and chromosomal localization of the genes.	PSME1 PSME2	1.47e-04	14	45	2	9218537
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SIX5 HSPA4L SYNE2 BRD9 SEC16A	1.60e-04	398	45	5	35016035
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MCM4 AFDN MRPL55 BRD9	1.73e-04	215	45	4	35973513
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MCM4 AFDN CLINT1 ELL SMC6 BRD9 SEC16A	2.09e-04	954	45	7	36373674
Pubmed	Structural analysis and chromosomal localization of the mouse Psmb5 gene coding for the constitutively expressed beta-type proteasome subunit.	PSME1 PSME2	2.20e-04	17	45	2	9382924
Pubmed	Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action.	PSME1 PSME2 HSPA4L	2.35e-04	92	45	3	35530310
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MCM4 AFDN CLINT1 NCAPH2 AMER1 KLC3 SMC6 SEC16A	2.61e-04	1321	45	8	27173435
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MCM4 AFDN CLINT1 MPHOSPH9 HSPA4L SEC16A	2.89e-04	708	45	6	39231216
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	MCM4 SYNE2 SEC16A	3.09e-04	101	45	3	26949739
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	CEP350 MPHOSPH9 TMCC3 SYNE2	3.13e-04	251	45	4	29778605
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CEP350 POR CLINT1 MPHOSPH9 PSME1 SYNE2 SEC16A	3.71e-04	1049	45	7	27880917
Pubmed	Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.	CLINT1 SEC16A	3.72e-04	22	45	2	26950368
Pubmed	Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.	CLINT1 SEC16A	5.22e-04	26	45	2	24067654
Pubmed	Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors.	CLINT1 SLC25A10 SEC16A	5.76e-04	125	45	3	36030824
Pubmed	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	CEP350 POR CENPF LOX	5.97e-04	298	45	4	32353859
Pubmed	ESYT1 tethers the ER to mitochondria and is required for mitochondrial lipid and calcium homeostasis.	POR HSPA4L SYNE2 SLC25A10	6.04e-04	299	45	4	37931956
Pubmed	Novel interactors and a role for supervillin in early cytokinesis.	MPHOSPH9 CENPF	6.06e-04	28	45	2	20309963
Pubmed	Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, and cytoskeletal function in the androgen-insensitive tfm mouse testis.	RIMS2 SLC25A10	7.92e-04	32	45	2	17332066
Pubmed	RNA microarray analysis in prenatal mouse cochlea reveals novel IGF-I target genes: implication of MEF2 and FOXM1 transcription factors.	SIX5 AKT2	7.92e-04	32	45	2	20111592
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	CLINT1 AMER1 SLC25A10 SEC16A	7.97e-04	322	45	4	39098523
Pubmed	Liver and brain differential expression of one-carbon metabolism genes during ontogenesis.	SARDH PCYT1B	8.43e-04	33	45	2	34702858
Pubmed	RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.	CLINT1 HSPA4L SEC16A	9.40e-04	148	45	3	35676246
Pubmed	Host PDZ-containing proteins targeted by SARS-CoV-2.	AFDN RIMS2	9.48e-04	35	45	2	33864728
Pubmed	Widespread macromolecular interaction perturbations in human genetic disorders.	FSD2 FUNDC1 NCAPH2 ZSCAN22 PSD4	9.64e-04	590	45	5	25910212
Pubmed	Structure and functions of the 20S and 26S proteasomes.	PSME1 PSME2	1.06e-03	37	45	2	8811196
Pubmed	An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.	PSME1 PSME2	1.06e-03	37	45	2	9811770
Pubmed	Hypermutation of HIV-1 DNA in the absence of the Vif protein.	PSME1 PSME2	1.06e-03	37	45	2	12750511
Pubmed	Death by deamination: a novel host restriction system for HIV-1.	PSME1 PSME2	1.06e-03	37	45	2	12914693
Pubmed	Good to CU.	PSME1 PSME2	1.06e-03	37	45	2	12840737
Pubmed	Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.	PSME1 PSME2	1.06e-03	37	45	2	12719574
Pubmed	Evidence for a newly discovered cellular anti-HIV-1 phenotype.	PSME1 PSME2	1.06e-03	37	45	2	9846577
Pubmed	DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.	PSME1 PSME2	1.06e-03	37	45	2	12830140
Pubmed	The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.	PSME1 PSME2	1.12e-03	38	45	2	12808465
Pubmed	Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.	PSME1 PSME2	1.12e-03	38	45	2	12808466
Pubmed	Virology. Weapons of mutational destruction.	PSME1 PSME2	1.12e-03	38	45	2	12920286
Pubmed	HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.	PSME1 PSME2	1.12e-03	38	45	2	14527406
Pubmed	Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.	CEP350 MPHOSPH9	1.12e-03	38	45	2	36674791
Pubmed	Degradation of HIV-1 integrase by the N-end rule pathway.	PSME1 PSME2	1.12e-03	38	45	2	10893419
Pubmed	The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.	PSME1 PSME2	1.12e-03	38	45	2	14557625
Pubmed	DNA deamination mediates innate immunity to retroviral infection.	PSME1 PSME2	1.12e-03	38	45	2	12809610
Pubmed	The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.	PSME1 PSME2	1.12e-03	38	45	2	12970355
Pubmed	The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.	PSME1 PSME2	1.12e-03	38	45	2	14614829
Pubmed	HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.	PSME1 PSME2	1.18e-03	39	45	2	14528301
Pubmed	The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.	PSME1 PSME2	1.24e-03	40	45	2	12419264
Pubmed	Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.	PSME1 PSME2	1.24e-03	40	45	2	12167863
Pubmed	The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.	PSME1 PSME2	1.24e-03	40	45	2	14528300
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	UBE2S SIX5 AKT2 ACP4 ZSCAN22 KLC3	1.04e-03	1192	45	6	chr19q13
Cytoband	19q13.43	UBE2S ZSCAN22	3.33e-03	87	45	2	19q13.43
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	SARDH GPSM1 SEC16A	4.00e-03	325	45	3	chr9q34
Cytoband	Ensembl 112 genes in cytogenetic band chr14q12	PSME1 PSME2	4.81e-03	105	45	2	chr14q12
Cytoband	9q34.3	GPSM1 SEC16A	4.90e-03	106	45	2	9q34.3
GeneFamily	AF4/FMR2 family\|Super elongation complex	ELL3 ELL	9.51e-05	9	30	2	1280
GeneFamily	Proteasome	PSME1 PSME2	2.30e-03	43	30	2	690
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	GPSM1 KLC3	1.55e-02	115	30	2	769
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP	UBE2S MCM4 GNA15 GNLY PSME1 PSME2	1.03e-05	292	45	6	M41140
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	UBE2S MCM4 NCAPH2 MPHOSPH9 CENPF MRPL55 SYNE2 SMC6	2.10e-05	694	45	8	M45767
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	MCM4 CACNG4 HSPA4L MXD1 KLC3	2.35e-05	200	45	5	M9215
Coexpression	PUJANA_BRCA2_PCC_NETWORK	UBE2S MCM4 GNA15 CLINT1 MPHOSPH9 CENPF	8.48e-05	426	45	6	M9516
Coexpression	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	UBE2S MCM4 MPHOSPH9 CENPF SMC6 SLC25A10	1.26e-04	458	45	6	M8520
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL	UBE2S MCM4 NCAPH2 MPHOSPH9 CENPF	1.36e-04	290	45	5	M45736
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL	UBE2S MCM4 GNA15 NCAPH2 CENPF SYNE2	1.59e-04	478	45	6	M45785
Coexpression	GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	USP25 GNA15 CENPF PCYT1B	2.41e-04	177	45	4	M6703
Coexpression	GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP	FUNDC1 ACOT6 CENPF ALKBH7	3.35e-04	193	45	4	M3536
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	USP25 CEP350 MPHOSPH9 SYNE2	3.62e-04	197	45	4	M5378
Coexpression	VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP	MCM4 GNLY CENPF	3.67e-04	81	45	3	M40892
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	USP25 PSME1 PSME2 ZCCHC2	3.69e-04	198	45	4	M8969
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	SIX5 GNA15 PSME1 ELL3	3.76e-04	199	45	4	M8113
Coexpression	GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN	FSD2 AFDN ELL3 MXD1	3.76e-04	199	45	4	M5983
Coexpression	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN	UBE2S TMCC3 SYNE2 SLC25A10	3.76e-04	199	45	4	M9170
Coexpression	GSE3039_CD4_TCELL_VS_B1_BCELL_UP	UBE2S MPHOSPH9 AMER1 SEC16A	3.84e-04	200	45	4	M6466
Coexpression	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	MCM4 MPHOSPH9 CENPF SMC6	3.84e-04	200	45	4	M4622
Coexpression	GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN	UBE2S MCM4 MPHOSPH9 PCYT1B	3.84e-04	200	45	4	M8069
Coexpression	GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN	USP25 PSME1 PSME2 ZCCHC2	3.84e-04	200	45	4	M7595
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	USP25 ELL3 TMCC3 MXD1	3.84e-04	200	45	4	M9348
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	USP25 PSME1 PSME2 ZCCHC2	3.84e-04	200	45	4	M8967
Coexpression	GSE27786_CD4_VS_CD8_TCELL_UP	CACNG4 CLINT1 ELL BRD9	3.84e-04	200	45	4	M4819
Coexpression	GSE27786_NKTCELL_VS_NEUTROPHIL_DN	AKT2 CACNG4 KLC3 BRD9	3.84e-04	200	45	4	M4869
Coexpression	GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN	USP25 CLINT1 PSME1 PSME2	3.84e-04	200	45	4	M8253
Coexpression	GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	CEP350 AMER1 ELL3 PSD4	3.84e-04	200	45	4	M7841
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN	UBE2S AFDN SMC6 BRD9	3.84e-04	200	45	4	M8576
Coexpression	GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP	SIX5 ELL PCYT1B PSD4	3.84e-04	200	45	4	M8488
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN	AKT2 PSME2 CENPF BRD9	3.84e-04	200	45	4	M7412
Coexpression	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	CEP350 FSD2 HSPA4L BRD9	3.84e-04	200	45	4	M4313
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	USP25 CEP350 POR CACNG4 SARDH RIMS2 CENPF SYNE2 SMC6	6.38e-06	654	44	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	USP25 CEP350 POR CACNG4 SARDH RIMS2 CENPF HSPA4L SYNE2 SMC6	2.55e-05	983	44	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	USP25 CEP350 CACNG4 RIMS2 CENPF SYNE2	5.59e-05	328	44	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	USP25 CACNG4 SARDH RIMS2 CENPF HSPA4L SYNE2	6.35e-05	493	44	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	CACNG4 SARDH RIMS2 CENPF SYNE2	1.14e-04	232	44	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GNA15 CACNG4 SARDH RIMS2 CENPF	1.54e-06	195	45	5	5812b1615676f3b77eb4769216b98b360c417c0d
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	CLINT1 LOX MXD1 SYNE2 SMC6	1.70e-06	199	45	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	IIH-CD4-CD8_1\|IIH / Condition, Cell_class and T cell subcluster	USP25 FSD2 AKT2 SARDH	1.39e-05	145	45	4	296b6b0eea3233d76742ea35252b2f54d4c27ab6
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBE2S MCM4 CENPF KLC3	2.72e-05	172	45	4	ba36581ae339191a12a6d3ead39eaf69d78be10e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UBE2S PSME2 CENPF LOX	3.25e-05	180	45	4	ed4966765a6b25456f68185cf0648c4a3a21d7fe
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MCM4 AFDN CACNG4 CENPF	3.69e-05	186	45	4	10565fce7e1b4ec88bc8e1ed6410a83800be5014
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	GNA15 HSPA4L MXD1 KLC3	3.93e-05	189	45	4	533c302df467d13ab639232daf4f8cafb808260b
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 CLINT1 HSPA4L SYNE2	4.09e-05	191	45	4	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 CLINT1 HSPA4L SYNE2	4.09e-05	191	45	4	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEP350 CLINT1 HSPA4L SYNE2	4.09e-05	191	45	4	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	3'_v3-blood-Lymphocytic_NK-Cycling_NK\|blood / Manually curated celltypes from each tissue	MCM4 GNLY NCAPH2 CENPF	4.35e-05	194	45	4	bf9734abaad603ade2a6a6940918aaf1e1c4e2cd
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MCM4 GNLY CENPF SLC25A10	4.53e-05	196	45	4	f70a2b227716a0df3c1aa6a414b822e63f209a43
ToppCell	CV-Moderate-1\|Moderate / Virus stimulation, Condition and Cluster	GNLY PSME1 PSME2 ZCCHC2	4.53e-05	196	45	4	b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	UBE2S MCM4 PSME2 CENPF	4.53e-05	196	45	4	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GNLY PSME1 PSME2 SYNE2	4.62e-05	197	45	4	879974aff3f887648a00b4659b46d9897c9eb467
ToppCell	severe-T/NK_proliferative\|World / disease stage, cell group and cell class	UBE2S MCM4 NCAPH2 CENPF	4.62e-05	197	45	4	6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	GNLY ZCCHC2 SYNE2 SEC16A	4.71e-05	198	45	4	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	UBE2S PSME1 SARDH CENPF	4.71e-05	198	45	4	beebbf637221021686e932c3d1bbf0f62cf95536
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM4 GNLY CENPF SYNE2	4.71e-05	198	45	4	80b105a7c7d00ea3b5e586831fbb755bd84f9d1a
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CEP350 CENPF SYNE2 SEC16A	4.71e-05	198	45	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 GNLY CENPF SYNE2	4.71e-05	198	45	4	c73e906d2d12d6eba0e606958be16e63a2292cd0
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 GNLY CENPF SYNE2	4.80e-05	199	45	4	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	Severe\|World / Disease group and Cell class	UBE2S MCM4 GNA15 CENPF	4.80e-05	199	45	4	b73ae402b258fcc17e6cd6d6045244eccfe38ef8
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	USP25 CEP350 SYNE2 SMC6	4.80e-05	199	45	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM4 GNLY CENPF SYNE2	4.80e-05	199	45	4	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM4 GNLY CENPF SYNE2	4.80e-05	199	45	4	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	UBE2S MPHOSPH9 CENPF SYNE2	4.80e-05	199	45	4	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM4 GNLY CENPF SYNE2	4.80e-05	199	45	4	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	PSME1 PSME2 ZCCHC2 SYNE2	4.80e-05	199	45	4	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MCM4 NCAPH2 CENPF SLC25A10	4.89e-05	200	45	4	5d11a2c0021805e78d97dc1638bf73ca1faede66
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UBE2S MCM4 NCAPH2 CENPF	4.89e-05	200	45	4	83cc5f7e812896d97950afbc6bdc10c4eb2f507a
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	MCM4 NCAPH2 CENPF SLC25A10	4.89e-05	200	45	4	97e47eb69d1d4cab45256acca9589837eb7817e7
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UBE2S MCM4 CENPF SYNE2	4.89e-05	200	45	4	dd5b753bb1333fa502b9d3a6d65a53a9882b2451
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MCM4 GNLY PSME2 CENPF	4.89e-05	200	45	4	d92d3bc63a56a604d7b1d49e62d4304e5e4017f2
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	UBE2S PSME1 PSME2 SYNE2	4.89e-05	200	45	4	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNLY PSME1 PSME2 SYNE2	4.89e-05	200	45	4	6c2543ff19a81c898f9e07d1fea97d16fa96e2bc
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GPSM1 CENPF PCYT1B	2.25e-04	117	45	3	f0c738b6b850733f9af68704172554177a1c1198
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GPSM1 CENPF PCYT1B	2.25e-04	117	45	3	b5cb9d69ddd42331134f7e4bd51bd1c31030893c
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACP4 ELL3 KLC3	2.92e-04	128	45	3	082b3dc312b033c9b21cf73499009a1dc049ee2b
ToppCell	LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GNA15 CENPF MXD1	3.72e-04	139	45	3	505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|367C / Donor, Lineage, Cell class and subclass (all cells)	GNLY SYNE2 PSD4	5.02e-04	154	45	3	a39877cdf7b441b5c953f744ed30f1d5acf4ea19
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GNA15 MXD1 PSD4	5.12e-04	155	45	3	93513bab53b40e9c3c91ab8e3316ea00a4f66cd2
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SIX5 GNLY TMCC3	5.21e-04	156	45	3	c11ca6b1b5029c15aab91273cece70a487287839
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-2\|TCGA-Colorectal / Sample_Type by Project: Shred V9	GNLY PSME1 HSPA4L	5.31e-04	157	45	3	67641089eeb1a502e01fb6ea35c3d19e21a5789e
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GNLY ELL3 KLC3	5.41e-04	158	45	3	1bf692f1e85f677cd62805437b7a59cfaf3b0449
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SIX5 MCM4 LOX	5.51e-04	159	45	3	b4bc888e978b1b577721b891b0af6ba9a1607044
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GNLY SYNE2 PSD4	5.51e-04	159	45	3	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GNA15 CLINT1 PSME1	5.51e-04	159	45	3	a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af
ToppCell	PND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSME1 PSME2 MXD1	5.61e-04	160	45	3	01f22cdb2a2f73776b7f91746e95c1850df94235
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-gdT\|ICU-NoSEP / Disease, Lineage and Cell Type	SIX5 GNLY SYNE2	5.61e-04	160	45	3	2798c5bd971407f27dd4d3a4831d63d9c88003c3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFDN GNA15 ELL3	5.61e-04	160	45	3	529034a1101d7772d82f86beb5c6fa9c9dd97067
ToppCell	PND07-Immune-Immune_Myeloid-DC-maDC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSME1 PSME2 MXD1	5.61e-04	160	45	3	7db30647b596f0c419087e6fabb9b99dcd5bddd4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UBE2S CENPF KLC3	5.72e-04	161	45	3	a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	UBE2S CENPF KLC3	5.72e-04	161	45	3	08920a716f6ec62538e361211455a30ad726d7be
ToppCell	human_hepatoblastoma-Tumor_cells-T7\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	GNLY ALKBH7 KLC3	5.82e-04	162	45	3	c6ace47daf32495b25793d39b72382978349597d
ToppCell	COVID-19_Severe-multiplets\|World / disease group, cell group and cell class	MCM4 GNLY CENPF	5.92e-04	163	45	3	6db4271c2d47a9c333964f36d2c32207115e52cd
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	MCM4 CENPF MXD1	5.92e-04	163	45	3	47300dec94dc66e965bf71fafff0a9fd24fae968
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNLY GPSM1 SYNE2	6.03e-04	164	45	3	ed7277f8980f96f5b3e4eed025d46d0942e123d7
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GNA15 CLINT1 PSME1	6.03e-04	164	45	3	662f74ad2656c0af158dbf9eb81d5bf70f54e529
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNLY GPSM1 SYNE2	6.03e-04	164	45	3	c4ad98106e8663caf7c1c15d30ec633d8bd8cf57
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POR MXD1 SLC25A10	6.14e-04	165	45	3	ce79d217df88035457cd58f679e72dd98722ae22
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UBE2S MCM4 CENPF	6.25e-04	166	45	3	2642544070564debe2deb2938d2c33997bf5ef02
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	UBE2S SARDH GPSM1	6.36e-04	167	45	3	9062577a4b7902c9a888d706589d1b05221c0fa8
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GNA15 MPHOSPH9 CENPF	6.47e-04	168	45	3	9b8a74abb83c64f0b5829dcb4275f722c82b45dc
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GNA15 MPHOSPH9 CENPF	6.47e-04	168	45	3	4b152b8d0f4a66faf664dfacb7914b18d60ce64a
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FSD2 ELL3 SMC6	6.47e-04	168	45	3	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FSD2 ELL3 SMC6	6.47e-04	168	45	3	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FSD2 ELL3 SMC6	6.47e-04	168	45	3	a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GNA15 MPHOSPH9 CENPF	6.47e-04	168	45	3	c3169ad8f4130ef18777ed86770bb722ffb5db85
ToppCell	PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSME1 PSME2 MXD1	6.58e-04	169	45	3	a83e4078db91ecedee637b28b12ec38640fe45f9
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SARDH RIMS2 SLC25A10	6.58e-04	169	45	3	922086f218135b734b7d370b871923e50141edce
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GNLY MPHOSPH9 ZSCAN22	6.58e-04	169	45	3	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	USP25 CLINT1 CENPF	6.58e-04	169	45	3	4db49b7eaea34e6558ee73b01e76315e99cc880b
ToppCell	facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SARDH RIMS2 SLC25A10	6.58e-04	169	45	3	ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad
ToppCell	PND10-Immune-Immune_Myeloid-DC-maDC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PSME1 PSME2 MXD1	6.58e-04	169	45	3	f914aa8899fa170a09da31e5fad86de897ea789b
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MCM4 CACNG4 LOX	6.58e-04	169	45	3	335619507857383c3b0b507cdf05d786ed59e585
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FSD2 ZSCAN22 LOX	6.69e-04	170	45	3	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UBE2S CENPF LOX	6.69e-04	170	45	3	21bfe070e63722672176052b386167ea4c3dc4e5
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo\|Lung / Manually curated celltypes from each tissue	GNLY CENPF SYNE2	6.81e-04	171	45	3	dfd4a15ab68ef5a9a1954b1b1540ae04017885a6
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POR TMCC3 MXD1	6.81e-04	171	45	3	5d0d6c1ff610a703ae0b834a12823c5ff9012932
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UBE2S ACOT6 CENPF	6.81e-04	171	45	3	d6114db2292fbb27b39d090d51fd305a135b1ccf
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UBE2S ACOT6 CENPF	6.81e-04	171	45	3	05014cf6746e6663e376fdd681f1b43a7081c603
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GNLY MPHOSPH9 SYNE2	6.81e-04	171	45	3	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFDN TMCC3 MXD1	6.92e-04	172	45	3	6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af
ToppCell	droplet-Marrow-BM_(NON-STC)-30m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBE2S CENPF SMC6	6.92e-04	172	45	3	31c5710fd7ebb221e703545595f5ec0ee3a32bcf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GPSM1 LOX TMCC3	6.92e-04	172	45	3	6c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MCM4 CENPF KLC3	6.92e-04	172	45	3	6fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	UBE2S PSME2 CENPF	6.92e-04	172	45	3	7f3d0ef18f5df1ed80498d435b0378ca398c0b88
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GPSM1 LOX TMCC3	6.92e-04	172	45	3	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	droplet-Marrow-BM_(NON-STC)\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBE2S CENPF SMC6	6.92e-04	172	45	3	6004327045f03d832fdabe6cb2f8b1b1db57789a
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CACNG4 ELL PCYT1B	6.92e-04	172	45	3	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	MCM4 NCAPH2 CENPF	7.04e-04	173	45	3	8a9dd85f718564c07cf3120ad648daeb60c94fc5
ToppCell	facs-Spleen-nan-24m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFDN PSME1 PSME2	7.04e-04	173	45	3	e07e126e9dac6f1160cb3191d2e8374f39155d0d
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MCM4 AMER1 CENPF	7.04e-04	173	45	3	20889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF ELL3 SYNE2	7.04e-04	173	45	3	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MCM4 AMER1 CENPF	7.04e-04	173	45	3	46e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCell	TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4\|TCGA-Adrenal / Sample_Type by Project: Shred V9	POR SIX5 AKT2	7.16e-04	174	45	3	15e2b9f46404ff9575e149024b24cb17b50b02b5
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELL SYNE2 SLC25A10	7.16e-04	174	45	3	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELL SYNE2 SLC25A10	7.16e-04	174	45	3	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GPSM1 LOX TMCC3	7.16e-04	174	45	3	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CEP350 CLINT1 SYNE2	3.88e-04	50	31	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Neighborhood of CDC20	UBE2S MCM4 CENPF	5.43e-04	56	31	3	GNF2_CDC20
Computational	Neighborhood of CCNB2	UBE2S MCM4 CENPF	5.72e-04	57	31	3	GNF2_CCNB2
Drug	PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A	AFDN GNA15 CACNG4 NCAPH2 CENPF ELL	2.32e-06	196	45	6	5928_DN
Disease	obsolete_red blood cell distribution width	AFDN NCAPH2 ZCCHC2 GPSM1 ELL MXD1 SYNE2 BRD9	4.59e-04	1347	41	8	EFO_0005192
Disease	mean reticulocyte volume	CEP350 MCM4 AFDN GNA15 CLINT1 NCAPH2	7.75e-04	799	41	6	EFO_0010701
Disease	colorectal cancer (is_marker_for)	AKT2 AMER1 LOX	1.36e-03	157	41	3	DOID:9256 (is_marker_for)
Disease	creatinine measurement	POR FSD2 AKT2 CENPF ELL PSD4	2.37e-03	995	41	6	EFO_0004518
Disease	alcohol use disorder (implicated_via_orthology)	AKT2 BRD9 PSD4	2.52e-03	195	41	3	DOID:1574 (implicated_via_orthology)
Disease	ecosanoids measurement	POR ACOT6	2.67e-03	55	41	2	EFO_0020044
Disease	nucleotide measurement	SYNE2 SMC6	4.65e-03	73	41	2	EFO_0010513

Protein segments in the cluster

Peptide	Gene	Start	Entry
SALEYLHSRDVVYRD	AKT2	261	P31751
YYSRLEAERRRQHDE	AFDN	1656	P55196
DFETDYAEYRILHAR	ELL3	306	Q9HB65
AEYSEYRDLHARIER	ELL	531	P55199
YYDDRSDHERERHKE	BRD9	51	Q9H8M2
FRAHARYRADARDEL	ACOT6	46	Q3I5F7
REAHAREAYTREAYG	AMER1	591	Q5JTC6
REAYGREAYAREAHT	AMER1	601	Q5JTC6
YAHALDGLYRVAREE	SLC25A10	141	Q9UBX3
EAYDRRLAHHLVALY	MCM4	656	P33991
ADYLERREREAEHGY	MXD1	16	Q05195
AREHIYDLRSLENYH	CLINT1	101	Q14677
EDYLYREELAQFHRD	POR	571	P16435
LLQDYERAAEYHLRH	GPSM1	301	Q86YR5
ERYEALRHCRYVDEV	PCYT1B	131	Q9Y5K3
PEYYDLARAHLRDEE	GNLY	26	P22749
HARHIADLRAYYESE	MPHOSPH9	451	Q99550
DVERHYARALSIYEA	KLC3	351	Q6P597
DAGIRAYYERRREFH	GNA15	141	P30679
AYYERRREFHLLDSA	GNA15	146	P30679
YEDSDHLSYRDSNRR	RIMS2	316	Q9UQ26
RYHELLREATEAAEY	ACP4	161	Q9BZG2
EYYRLAETRGARSDH	CPZ	331	Q66K79
RCYQDLHAEYESLRD	CENPF	751	P49454
DYDHDSSEYLLRIVR	CACNG4	91	Q9UBN1
DSYEVLDLTEYARRH	FUNDC1	16	Q8IVP5
RELYRDLALHFADDI	CEP350	366	Q5VT06
ASTAYRADVRDYDHR	LOX	246	P28300
YGLRDSRSEHERQYL	POLR3E	211	Q9NVU0
DYRQLVHELDEAEYR	PSME1	196	Q06323
YRYERLEDQLHDLTD	TMCC3	331	Q9ULS5
LERYDTYRDILEHHL	SYNE2	1116	Q8WXH0
LREAYRYTHGRASEE	FSD2	146	A1L4K1
RELEEHRLRKEYLEY	PSD4	956	Q8NDX1
QDLYLRARYHEAERA	SIX5	161	Q8N196
DYRALVHERDEAAYG	PSME2	186	Q9UL46
RAHEDYAYRRLLADE	SARDH	531	Q9UL12
ELEPELRRRRYEYDH	ALKBH7	51	Q9BT30
YLAAYADHADSRRLR	NCAPH2	366	Q6IBW4
DLARKDYHYLRDSEA	ZCCHC2	136	Q9C0B9
EYDAYRREHSAFGDR	SEC16A	1296	O15027
YEQELSDDLHVERYR	MRPL55	106	Q7Z7F7
IEAYRNKDERYDHLD	HSPA4L	716	O95757
YRGHDEELISHYRRE	USP25	916	Q9UHP3
EFRNEIYDVRHRAAY	SMC6	566	Q96SB8
YEEYAARARLLTEIH	UBE2S	141	Q16763
EAARLRFRHFRYEEA	ZSCAN22	46	P10073